{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T08:40:29Z","timestamp":1777624829484,"version":"3.51.4"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,28]]},"DOI":"10.7759\/cureus.107911","type":"journal-article","created":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T23:40:42Z","timestamp":1777419642000},"source":"Crossref","is-referenced-by-count":0,"title":["Recurrent IgG4 Disease-Related Tubulointerstitial Nephritis Treated With Rituximab As Maintenance Therapy"],"prefix":"10.7759","author":[{"given":"Alejandro","family":"Valdesuso","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jill","family":"Nehrbas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Dan Khoa Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rakesh","family":"Malhotra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tushar","family":"Chopra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ackd.2016.12.001","article-title":"IgG4-related tubulointerstitial nephritis","volume":"24","author":"Zhang P","year":"2017","unstructured":"Zhang P, Cornell LD. IgG4-related tubulointerstitial nephritis. Adv Chronic Kidney Dis. 2017, 24:94-100. 10.1053\/j.ackd.2016.12.001","journal-title":"Adv Chronic Kidney Dis"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.635706","article-title":"Renal involvement in IgG4-related disease: from sunlight to twilight","volume":"8","author":"Capecchi R","year":"2021","unstructured":"Capecchi R, Giannese D, Moriconi D, et al.. Renal involvement in IgG4-related disease: from sunlight to twilight. Front Med (Lausanne). 2021, 8:635706. 10.3389\/fmed.2021.635706","journal-title":"Front Med (Lausanne)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2021-241942","article-title":"IgG4-related tubulointerstitial nephritis","volume":"14","author":"Momoniat T","year":"2021","unstructured":"Momoniat T, Jacob D, Duhli N, Jorna T. IgG4-related tubulointerstitial nephritis. BMJ Case Rep. 2021, 14:10.1136\/bcr-2021-241942","journal-title":"BMJ Case Rep"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.4132\/jptm.2015.11.09","article-title":"Overview of IgG4-related tubulointerstitial nephritis and its mimickers","volume":"50","author":"Jeong HJ","year":"2016","unstructured":"Jeong HJ, Shin SJ, Lim BJ. Overview of IgG4-related tubulointerstitial nephritis and its mimickers. J Pathol Transl Med. 2016, 50:26-36. 10.4132\/jptm.2015.11.09","journal-title":"J Pathol Transl Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-206605","article-title":"Rituximab for IgG4-related disease: a prospective, open-label trial","volume":"74","author":"Carruthers MN","year":"2015","unstructured":"Carruthers MN, Topazian MD, Khosroshahi A, et al.. Rituximab for IgG4-related disease: a prospective, open-label trial. Ann Rheum Dis. 2015, 74:1171-7. 10.1136\/annrheumdis-2014-206605","journal-title":"Ann Rheum Dis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0183844","article-title":"Long-term efficacy and safety of rituximab in IgG4-related disease: data from a French nationwide study of thirty-three patients","volume":"12","author":"Ebbo M","year":"2017","unstructured":"Ebbo M, Grados A, Samson M, et al.. Long-term efficacy and safety of rituximab in IgG4-related disease: data from a French nationwide study of thirty-three patients. PLoS One. 2017, 12:e0183844. 10.1371\/journal.pone.0183844","journal-title":"PLoS One"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.12675","article-title":"IgG4-related tubulointerstitial nephritis: a prospective analysis","volume":"19","author":"Nada R","year":"2016","unstructured":"Nada R, Ramachandran R, Kumar A, et al.. IgG4-related tubulointerstitial nephritis: a prospective analysis. Int J Rheum Dis. 2016, 19:721-9. 10.1111\/1756-185X.12675","journal-title":"Int J Rheum Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1159\/000500296","article-title":"IgG4-related kidney disease: a curious case of interstitial nephritis with hypocomplementemia","volume":"9","author":"Wong ET","year":"2019","unstructured":"Wong ET, Lahiri M, Teh M, Leo CC. IgG4-related kidney disease: a curious case of interstitial nephritis with hypocomplementemia. Case Rep Nephrol Dial. 2019, 9:49-54. 10.1159\/000500296","journal-title":"Case Rep Nephrol Dial"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8020258","article-title":"Kidney involvement in patients with type 1 autoimmune pancreatitis","volume":"8","author":"Vujasinovic M","year":"2019","unstructured":"Vujasinovic M, Pozzi Mucelli RM, Valente R, Verbeke CS, Haas SL, L\u00f6hr JM. Kidney involvement in patients with type 1 autoimmune pancreatitis. J Clin Med. 2019, 8:10.3390\/jcm8020258","journal-title":"J Clin Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/MNH.0000000000000102","article-title":"IgG4-related kidney disease--an update","volume":"24","author":"Kawano M","year":"2015","unstructured":"Kawano M, Saeki T. IgG4-related kidney disease--an update. Curr Opin Nephrol Hypertens. 2015, 24:193-201. 10.1097\/MNH.0000000000000102","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2011010062","article-title":"Diagnosis of IgG4-related tubulointerstitial nephritis","volume":"22","author":"Raissian Y","year":"2011","unstructured":"Raissian Y, Nasr SH, Larsen CP, et al.. Diagnosis of IgG4-related tubulointerstitial nephritis. J Am Soc Nephrol. 2011, 22:1343-52. 10.1681\/ASN.2011010062","journal-title":"J Am Soc Nephrol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/art.39132","article-title":"International consensus guidance statement on the management and treatment of IgG4-related disease","volume":"67","author":"Khosroshahi A","year":"2015","unstructured":"Khosroshahi A, Wallace ZS, Crowe JL, et al.. International consensus guidance statement on the management and treatment of IgG4-related disease. Arthritis Rheumatol. 2015, 67:1688-99. 10.1002\/art.39132","journal-title":"Arthritis Rheumatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000004002","article-title":"Therapeutic approach to IgG4-related disease: a systematic review","volume":"95","author":"Brito-Zer\u00f3n P","year":"2016","unstructured":"Brito-Zer\u00f3n P, Kostov B, Bosch X, Acar-Denizli N, Ramos-Casals M, Stone JH. Therapeutic approach to IgG4-related disease: a systematic review. Medicine (Baltimore). 2016, 95:e4002. 10.1097\/MD.0000000000004002","journal-title":"Medicine (Baltimore)"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000001366","article-title":"Rituximab for the treatment of IgG4-related tubulointerstitial nephritis: case report and review of the literature","volume":"94","author":"McMahon BA","year":"2015","unstructured":"McMahon BA, Novick T, Scheel PJ, Bagnasco S, Atta MG. Rituximab for the treatment of IgG4-related tubulointerstitial nephritis: case report and review of the literature. Medicine (Baltimore). 2015, 94:e1366. 10.1097\/MD.0000000000001366","journal-title":"Medicine (Baltimore)"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kev438","article-title":"Predictors of disease relapse in IgG4-related disease following rituximab","author":"Wallace ZS","year":"2016","unstructured":"Wallace ZS, Mattoo H, Mahajan VS, et al.. Predictors of disease relapse in IgG4-related disease following rituximab. 2016. 10.1093\/rheumatology\/kev438"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2013.393","article-title":"IgG4-related kidney disease","volume":"85","author":"Saeki T","year":"2014","unstructured":"Saeki T, Kawano M. IgG4-related kidney disease. Kidney Int. 2014, 85:251-7. 10.1038\/ki.2013.393","journal-title":"Kidney Int"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.25095","article-title":"IgG4-related kidney disease: the effects of a rituximab-based immunosuppressive therapy","volume":"9","author":"Quattrocchio G","year":"2018","unstructured":"Quattrocchio G, Barreca A, Demarchi A, et al.. IgG4-related kidney disease: the effects of a rituximab-based immunosuppressive therapy. Oncotarget. 2018, 9:21337-47. 10.18632\/oncotarget.25095","journal-title":"Oncotarget"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1002\/art.27435","article-title":"Rituximab therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4-related systemic disease","volume":"62","author":"Khosroshahi A","year":"2010","unstructured":"Khosroshahi A, Bloch DB, Deshpande V, Stone JH. Rituximab therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4-related systemic disease. Arthritis Rheum. 2010, 62:1755-62. 10.1002\/art.27435","journal-title":"Arthritis Rheum"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-020-0500-7","article-title":"IgG4-related disease: an update on pathophysiology and implications for clinical care","volume":"16","author":"Perugino CA","year":"2020","unstructured":"Perugino CA, Stone JH. IgG4-related disease: an update on pathophysiology and implications for clinical care. Nat Rev Rheumatol. 2020, 16:702-14. 10.1038\/s41584-020-0500-7","journal-title":"Nat Rev Rheumatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/385678-recurrent-igg4-disease-related-tubulointerstitial-nephritis-treated-with-rituximab-as-maintenance-therapy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T23:40:42Z","timestamp":1777419642000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/385678-recurrent-igg4-disease-related-tubulointerstitial-nephritis-treated-with-rituximab-as-maintenance-therapy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,28]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.107911","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,28]]}}}